Scientific paper - Original scientific paper
Gut microbiome dysbiosis and endotoxemia - Additional pathophysiological explanation for increased COVID-19 severity in obesity
Obesity Medicine, 20 (2020); 100302. https://doi.org/10.1016/j.obmed.2020.100302


Cite this document

Belančić, A. (2020). Gut microbiome dysbiosis and endotoxemia - Additional pathophysiological explanation for increased COVID-19 severity in obesity. Obesity Medicine, 20., 100302. doi: 10.1016/j.obmed.2020.100302

Belančić, Andrej. "Gut microbiome dysbiosis and endotoxemia - Additional pathophysiological explanation for increased COVID-19 severity in obesity." Obesity Medicine, vol. 20, 2020, pp. 100302. https://doi.org/10.1016/j.obmed.2020.100302

Belančić, Andrej. "Gut microbiome dysbiosis and endotoxemia - Additional pathophysiological explanation for increased COVID-19 severity in obesity." Obesity Medicine 20 (2020): 100302. https://doi.org/10.1016/j.obmed.2020.100302

Belančić, A. (2020) 'Gut microbiome dysbiosis and endotoxemia - Additional pathophysiological explanation for increased COVID-19 severity in obesity', Obesity Medicine, 20, pp. 100302. doi: 10.1016/j.obmed.2020.100302

Belančić A. Gut microbiome dysbiosis and endotoxemia - Additional pathophysiological explanation for increased COVID-19 severity in obesity. Obesity Medicine [Internet]. 2020 December [cited 2024 June 16];20:100302. doi: 10.1016/j.obmed.2020.100302

A. Belančić, "Gut microbiome dysbiosis and endotoxemia - Additional pathophysiological explanation for increased COVID-19 severity in obesity", Obesity Medicine, vol. 20, pp. 100302, December 2020. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:776025. [Accessed: 16 June 2024]